These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7944529)

  • 1. Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.
    Verkerk PH; van Spronsen FJ; Smit GP; Sengers RC
    Arch Dis Child; 1994 Aug; 71(2):114-8. PubMed ID: 7944529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National Dutch PKU Steering Committee.
    van Spronsen FJ; Verkerk PH; van Houten M; Smit GP; van der Meer SB; Bakker HD; Sengers RC
    Acta Paediatr; 1997 Aug; 86(8):816-8. PubMed ID: 9307159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.
    Holm VA; Kronmal RA; Williamson M; Roche AF
    Pediatrics; 1979 May; 63(5):700-7. PubMed ID: 312490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and skeletal maturation in children with phenylketonuria.
    Schaefer F; Burgard P; Batzler U; Rupp A; Schmidt H; Gilli G; Bickel H; Bremer HJ
    Acta Paediatr; 1994 May; 83(5):534-41. PubMed ID: 8086734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical growth in phenylketonuria: I. A retrospective study.
    Holm VA; Knox WE
    Pediatrics; 1979 May; 63(5):694-9. PubMed ID: 312489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical growth of children treated for phenylketonuria.
    McBurnie MA; Kronmal RA; Schuett VE; Koch R; Azeng CG
    Ann Hum Biol; 1991; 18(4):357-68. PubMed ID: 1750755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].
    Verkerk PH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2302-5. PubMed ID: 7501062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.
    Belanger-Quintana A; Martínez-Pardo M
    Mol Genet Metab; 2011 Dec; 104(4):480-4. PubMed ID: 21878401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.
    Hoeksma M; Van Rijn M; Verkerk PH; Bosch AM; Mulder MF; de Klerk JB; de Koning TJ; Rubio-Gozalbo E; de Vries M; Sauer PJ; van Spronsen FJ
    J Inherit Metab Dis; 2005; 28(6):845-54. PubMed ID: 16435176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth parameters in newborns with hyperphenylalaninaemia.
    Zaffanello M; Zamboni G; Tatò L
    Paediatr Perinat Epidemiol; 2002 Jul; 16(3):274-7. PubMed ID: 12123441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No reduction in birth weight in phenylketonuria.
    Tillotson SL; Costello PM; Smith I
    Eur J Pediatr; 1995 Oct; 154(10):847-9. PubMed ID: 8529686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth, Protein and Energy Intake in Children with PKU Taking a Weaning Protein Substitute in the First Two Years of Life: A Case-Control Study.
    Evans S; Daly A; Wildgoose J; Cochrane B; Chahal S; Ashmore C; Loveridge N; MacDonald A
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30841589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception (an interim report from the UK Phenylketonuria Register).
    Smith I; Glossop J; Beasley M
    J Inherit Metab Dis; 1990; 13(4):651-7. PubMed ID: 2122128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [15 years of national screening for phenylketonuria in The Netherlands; 4th Report of the National Commission for Management of Phenylketonuria].
    Verkerk PH; Vaandrager GJ; Sengers RC
    Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2533-6. PubMed ID: 2270129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of physical development in children with classical phenylketonuria].
    Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
    Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study.
    Farooqi A; Hägglöf B; Sedin G; Gothefors L; Serenius F
    Pediatrics; 2006 Nov; 118(5):e1452-65. PubMed ID: 17079546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Size at Birth or Abnormal Intrauterine Growth Trajectory: Which Matters More for Child Growth?
    Hutcheon JA; Jacobsen GW; Kramer MS; Martinussen M; Platt RW
    Am J Epidemiol; 2016 Jun; 183(12):1107-13. PubMed ID: 27257112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of perinatal risk factors on growth in very preterm infants at 2 years of age: the Leiden Follow-Up Project on Prematurity.
    Rijken M; Wit JM; Le Cessie S; Veen S;
    Early Hum Dev; 2007 Aug; 83(8):527-34. PubMed ID: 17140751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
    de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
    Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.